bUY PEA-NBOMe Cas 3241-03-0

bUY PEA-NBOMe Cas 3241-03-0

PEA-NBOMe, also known as N-(2-methoxybenzyl)phenethylamine, is a drug of the phenethylamine and N-benzylphenethylamine (NB; NBOMe) families related to phenethylamine (PEA).^[1][2] It is the N-(2-methoxybenzyl) derivative of phenethylamine.^[1][2] The drug is a parent compound of the NBOMe family of psychedelic drugs, such as 25I-NBOMe.^[1][2][3] No data on the pharmacology or toxicity of PEA-NBOMe are available.^[1][2] In any case, based on structure–activity relationships, PEA-NBOMe might produce stimulant and/or hallucinogenic effects.^[1][2] The drug was encountered as a novel designer drug online in 2024.^[1][2] It is not a controlled substance in Canada as of 2025.^[4]